< Back to scientific publications

Magazine 9.06

Use of Plerixafor in Predicted and Proven Poor Mobilizer (according to GITMO criteria). Experience of Policlinico Universitario Tor Vergata”

Authors: Postorino M., Rossi R., Zizzari A. G., Marchesi F., Provenzano I., Franceschini L., Pupo L., Rizzo M., .Giannì L, Gumenyuk S., De Santis G., Renzi D., Guiducci G., Fiorelli E., Coniglione F., Puliti R., Berrini A., Dauri M..

Date: 2012

Scope of interest: Haematology




You may also be interested in:

Magazine 4,539

PUFA supplements and diabetes

Authors: Abbatecola AM, Evans WJ, Paolisso G.

Date: 2009

Scope of interest: pharmacology


Read details
Magazine 2,278

Residual C-peptide secretion and endothelial function in type 2 diabetic patients

Authors: Manzella D, Spider E, Abbatecola AM, Grella R, Paolisso G

Date: 2003

Scope of interest: physiopathological mechanisms


Read details
Magazine 7.19

Switch From Originator to Equivalent Drug in the Era of Generic Antiepileptic Drugs: Study of Keppra Versus Epitiram Clinical Equivalence.

Authors: Fanella M, Morano A, Fattouch J, Albini M, Basili LM, Casciato S, Manfredi M, Giallonardo AT, Di Bonaventura C.

Date: 2017

Scope of interest: Epilepsy


Read details